Search Within

Neeta Pandit-Taskar

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (51)
  2. Meeting Abstract (50)
  3. Book Section (2)
Groups
  1. GSK Faculty (103)
  2. Molecular Imaging and Therapy Service (103)
  3. Molecular Pharmacology and Chemistry Program Faculty (103)
  4. Radiology, Department of (103)
  5. Sloan Kettering Institute Faculty (103)
  6. Medical Physics (62)

More Groups

People
  1. Steven Larson (99)
  2. Jorge Carrasquillo (53)
  3. Pat Zanzonico (35)
  4. Serge Lyashchenko (35)
  5. Michael Morris (30)
  6. Howard Scher (29)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (7)
  4. 2021 (3)
  5. 2020 (1)
  6. 2019 (8)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Journal of Nuclear Medicine (21)
  3. Neuro-Oncology (9)
  4. Pediatric Blood and Cancer (8)
  5. Clinical Cancer Research (7)
  6. European Journal of Nuclear Medicine and Molecular Imaging (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Society of Nuclear Medicine (21)
  3. Springer (14)
  4. American Association for Cancer Research (10)
  5. Oxford University Press (9)
  6. Wiley Periodicals, Inc (8)

More Publishers

Results (103)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J. A.; O'Donoghue, J. A.; Humm, J.; Lyashchenko, S. K.; Haupt, E. C.; Bander, N. H.; Tagawa, S. T.; Holland, J. P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Diagnostic imaging
    Book Section

    Sala, E.; Lakhman, Y.; Ma, W.; Pannu, H.; Li, D.; Pandit-Taskar, N.; Hricak, H.
    In Barakat, R. R.; Berchuck, A.; Markman, M.; Randall, M. E. (Eds.) Principles and Practice of Gynecologic Oncology. 6th ed (2013)

    Fulltext@MSK | Save
  • Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer
    Journal Article

    Gemignani, M. L.; Patil, S.; Seshan, V. E.; Sampson, M.; Humm, J. L.; Lewis, J. S.; Brogi, E.; Larson, S. M.; Morrow, M.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Phase II study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer
    Journal Article

    Tagawa, S. T.; Milowsky, M. I.; Morris, M.; Vallabhajosula, S.; Christos, P.; Akhtar, N. H.; Osborne, J.; Goldsmith, S. J.; Larson, S.; Taskar, N. P.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Repetitively dosed docetaxel and 153samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer
    Journal Article

    Autio, K. A.; Pandit-Taskar, N.; Carrasquillo, J. A.; Stephenson, R. D.; Slovin, S. F.; Rathkopf, D. E.; Hong, C.; Heller, G.; Scher, H. I.; Larson, S. M.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Phase i pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer
    Journal Article

    Carrasquillo, J. A.; O'Donoghue, J. A.; Pandit-Taskar, N.; Humm, J. L.; Rathkopf, D. E.; Slovin, S. F.; Williamson, M. J.; Lacuna, K.; Aksnes, A. K.; Larson, S. M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2013)

    Fulltext@MSK | Save
  • (124)I-cG250 PET scan for early detection of response to sunitinib in patients (Pts) with metastatic clear cell renal cell carcinoma (MccRCC)
    Meeting Abstract

    Larson, S. M.; Motzer, R. J.; Pandit-Taskar, N.; Bartz, R.; Feldman, D. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 ((225)Ac-lintuzumab) (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Ryan, C.; Frattini, M. G.; Cicic, D.; Larson, S. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Zikaras, K.; Frattini, M. G.; Maslak, P. G.; Cicic, D.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • (124)I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET
    Journal Article

    O'Donoghue, J. A.; Smith-Jones, P. M.; Humm, J. L.; Ruan, S.; Pryma, D. A.; Jungbluth, A. A.; Divgi, C. R.; Carrasquillo, J. A.; Pandit-Taskar, N.; Fong, Y.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save